211 related articles for article (PubMed ID: 28521146)
1. Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Psychiatry Res; 2017 Sep; 255():36-41. PubMed ID: 28521146
[TBL] [Abstract][Full Text] [Related]
2. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study.
Barbeito S; Vega P; Ruiz de Azúa S; Saenz M; Martinez-Cengotitabengoa M; González-Ortega I; Bermudez C; Hernanz M; Corres BF; González-Pinto A
BMC Psychiatry; 2013 Dec; 13():326. PubMed ID: 24289797
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
Reid S; Bhattacharyya S
Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
[TBL] [Abstract][Full Text] [Related]
5. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis.
Faridi K; Joober R; Malla A
Schizophr Res; 2012 Oct; 141(1):78-82. PubMed ID: 22910403
[TBL] [Abstract][Full Text] [Related]
6. Substance use, medication adherence and outcome one year following a first episode of psychosis.
Colizzi M; Carra E; Fraietta S; Lally J; Quattrone D; Bonaccorso S; Mondelli V; Ajnakina O; Dazzan P; Trotta A; Sideli L; Kolliakou A; Gaughran F; Khondoker M; David AS; Murray RM; MacCabe JH; Di Forti M
Schizophr Res; 2016 Feb; 170(2-3):311-7. PubMed ID: 26718334
[TBL] [Abstract][Full Text] [Related]
7. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
Hides L; Dawe S; Kavanagh DJ; Young RM
Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis.
Foglia E; Schoeler T; Klamerus E; Morgan K; Bhattacharyya S
Psychol Med; 2017 Jul; 47(10):1691-1705. PubMed ID: 28179039
[TBL] [Abstract][Full Text] [Related]
9. Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.
Daneault JG; Maraj A; Lepage M; Malla A; Schmitz N; Iyer SN; Joober R; Shah JL
Acta Psychiatr Scand; 2019 Apr; 139(4):336-347. PubMed ID: 30712261
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning.
Sánchez-Gutiérrez T; Fernandez-Castilla B; Barbeito S; González-Pinto A; Becerra-García JA; Calvo A
Eur Psychiatry; 2020 Jan; 63(1):e6. PubMed ID: 32093788
[TBL] [Abstract][Full Text] [Related]
11. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
[TBL] [Abstract][Full Text] [Related]
12. Medication-adherent first-episode psychosis patients also relapse: why?
Levy E; Pawliuk N; Joober R; Abadi S; Malla A
Can J Psychiatry; 2012 Feb; 57(2):78-84. PubMed ID: 22340147
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
Hui CLM; Poon VWY; Ko WT; Miao HY; Chang WC; Lee EHM; Chan SKW; Lin J; Chen EYH
Schizophr Res; 2016 Jul; 174(1-3):144-149. PubMed ID: 27050476
[TBL] [Abstract][Full Text] [Related]
14. Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.
Schoeler T; Petros N; Di Forti M; Pingault JB; Klamerus E; Foglia E; Small A; Murray R; Bhattacharyya S
JAMA Psychiatry; 2016 Nov; 73(11):1173-1179. PubMed ID: 27680429
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
[TBL] [Abstract][Full Text] [Related]
16. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
[TBL] [Abstract][Full Text] [Related]
17. Moderating role of cannabis use between insight and depression in early psychosis.
Elowe J; Golay P; Baumann PS; Solida-Tozzi A; Conus P
Schizophr Res; 2020 Jan; 215():61-65. PubMed ID: 31780343
[TBL] [Abstract][Full Text] [Related]
18. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
19. Non-adherence to antipsychotic medication in first-episode psychosis patients.
Hickling LM; Kouvaras S; Nterian Z; Perez-Iglesias R
Psychiatry Res; 2018 Jun; 264():151-154. PubMed ID: 29631247
[TBL] [Abstract][Full Text] [Related]
20. Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study.
Gerlach J; Koret B; Gereš N; Matić K; Prskalo-Čule D; Zadravec Vrbanc T; Lovretić V; Skopljak K; Matoš T; Šimunović Filipčić I; Filipčić I
Psychiatr Danub; 2019 Jun; 31(Suppl 2):162-170. PubMed ID: 31158117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
